📣 VC round data is live. Check it out!
- Public Comps
- Monsenso
Monsenso Valuation Multiples
Discover revenue and EBITDA valuation multiples for Monsenso and similar public comparables like 1933 Industries, Telemedycyna Polska, Alternate Health, Aino Health and more.
Monsenso Overview
About Monsenso
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. Its mHealth solution for mental health consists of three components, namely A smartphone app for individuals, A web portal for clinicians & users, and A smartphone app for careers.
Founded
2013
HQ

Employees
13
Website
Sectors
Financials (FY)
EV
$2M
Valuation Multiples
Start free trialMonsenso Financials
Monsenso reported last fiscal year revenue of $1M and negative EBITDA of ($459K).
In the same fiscal year, Monsenso generated $560K in gross profit, ($459K) in EBITDA losses, and had net loss of ($1M).
Monsenso P&L
In the most recent fiscal year, Monsenso reported revenue of $1M and EBITDA of ($459K).
Monsenso is unprofitable as of last fiscal year, with gross margin of 40%, EBITDA margin of (33%), and net margin of (81%).
Financial data powered by Morningstar, Inc.
Monsenso Stock Performance
Monsenso has current market cap of $2M, and enterprise value of $2M.
Market Cap Evolution
Monsenso's stock price is $0.03.
Monsenso share price increased by 39.3% in the last 30 days, and decreased by 24.0% in the last year.
Monsenso has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $2M | -0.1% | 39.3% | 57.8% | -24.0% | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMonsenso Valuation Multiples
Monsenso trades at 1.7x EV/Revenue multiple, and (5.1x) EV/EBITDA.
Monsenso Financial Valuation Multiples
As of May 19, 2026, Monsenso has market cap of $2M and EV of $2M.
Monsenso has a P/E ratio of (1.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Monsenso Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Monsenso Margins & Growth Rates
In the most recent fiscal year, Monsenso reported gross margin of 40%, EBITDA margin of (33%), and net margin of (81%).
Monsenso Margins
Monsenso Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Monsenso Operational KPIs
Monsenso's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Monsenso Competitors
Monsenso competitors include 1933 Industries, Telemedycyna Polska, Alternate Health, Aino Health, Premier Health Of America, Clarent, Brain+, Medondo Holding, Ludwig Enterprises and Feedback.
Most Monsenso public comparables operate across Healthcare Software, Health Data & Analytics, EHR & Practice Management, HealthTech, B2B SaaS and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.0x | — | 17.5x | — | |||
| 1.6x | — | (7.4x) | — | |||
| — | — | — | — | |||
| 1.2x | — | (13.4x) | — | |||
| 0.4x | 0.4x | (12.3x) | — | |||
| — | — | — | — | |||
| — | — | — | — | |||
| 4.7x | — | (7.0x) | — | |||
This data is available for Pro users. Sign up to see all Monsenso competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Monsenso
| When was Monsenso founded? | Monsenso was founded in 2013. |
| Where is Monsenso headquartered? | Monsenso is headquartered in Denmark. |
| How many employees does Monsenso have? | As of today, Monsenso has over 13 employees. |
| Is Monsenso publicly listed? | Yes, Monsenso is a public company listed on Nasdaq Copenhagen. |
| What is the stock symbol of Monsenso? | Monsenso trades under MONSO ticker. |
| When did Monsenso go public? | Monsenso went public in 2020. |
| Who are competitors of Monsenso? | Monsenso main competitors include 1933 Industries, Telemedycyna Polska, Alternate Health, Aino Health, Premier Health Of America, Clarent, Brain+, Medondo Holding, Ludwig Enterprises, Feedback. |
| What is the current market cap of Monsenso? | Monsenso's current market cap is $2M. |
| What is the current revenue of Monsenso? | Monsenso's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Monsenso? | Current revenue multiple of Monsenso is 1.7x. |
| Is Monsenso profitable? | No, Monsenso is not profitable. |
| How many companies Monsenso has acquired to date? | Monsenso hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Monsenso has invested to date? | Monsenso hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Monsenso
Lists including Monsenso
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.